Canada’s Reforms on Psychedelics Are Slowly Taking Shape
A lab researcher removes a psilocybin mushroom from a container at the Numinus Bioscience lab in Nanaimo, British Columbia.
Photographer: James MacDonald/BloombergWelcome to the Dose, Bloomberg’s newsletter about the cannabis and psychedelics industries.
A tectonic shift is taking place as previously underground drugs are thrust into the mainstream. As I’ve covered alcohol, tobacco and cannabis for Bloomberg News, a common theme has emerged: Mental-health care is ripe for disruption, and yesterday’s party drugs are tomorrow’s cures.